|
T.TST
|
I agree, beech. For Bioniche to have a strong commercial presence in the U.S....
|
|
T.TST
|
How much assurance BNC has for the demand of its Econiche while it is...
|
|
T.TST
|
Are these actual exercise of options or just mere recording of options handed...
|
|
T.TST
|
chipinski! Hamilton! that brings back old memory. I used to go to Appleby...
|
|
T.TST
|
beech, the part of the BNC business that has the highest potential of...
|
|
T.TST
|
Its PR strategy. It is mostly known as an animal health company. Frankly, who...
|
|
T.TST
|
Thanks, Jimmy.
|
|
T.TST
|
I can't seem to make the search at SEDAR work. Please help! Thanks.
|
|
T.TST
|
With the exclusive right for data release and further testing, Endo can put a...
|
|
T.TST
|
That you guys keep talking about a buy-out. With the global right to sell...
|
|
T.TST
|
The tone in the discussions on this stock is definitely turning downward. I...
|
|
T.TST
|
Thanks for the heads-up.Short term, I hope this will kick ENDO into action...
|
|
T.TST
|
Beech, do you mean "break-out"? A buyout should fetch more than $5...
|
|
T.TST
|
Thanks. That was funny. Good laugh to start the weekend.
|
|
T.TST
|
Arte, it's a two edge sword. Listing on NASDAQ risks U.S. MM manipulation...
|
|
T.TST
|
Hello Dr. Hwang, Thank you for your question and commentary. ...
|
|
T.TST
|
Beech, thx for the clear insight on the peril of Nasdaq listing. I still...
|
|
T.TST
|
I read the announcement from Bioniche again and my understanding is that...
|
|
T.TST
|
First of all, no US Pharma company would want to buy out Bioniche animal...
|
|
T.TST
|
In terms of share price appreciation %, which one will benefit more:1 from...
|